Clinical trial

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

NCT00268788 · University of Aarhus, Other · Completed

Key facts

NCT number NCT00268788
Title Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Official title A Controlled Cross-Over Trial of Subcutaneous Versus Intravenous Immunoglobulin for Multifocal Motor Neuropathy
Lead sponsor University of Aarhus, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Multifocal Motor Neuropathy
Intervention type Drug
Interventions Subcutaneous immunoglobulin, Intravenous immunoglobulin
Enrollment 10
Start date Aug 1, 2005
Primary completion Feb 1, 2008
Completion Feb 1, 2008
First posted Dec 22, 2005
Last update posted Feb 21, 2008
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies